Lou Hawthorne

Lou Hawthorne

Lou Hawthorne is a seasoned CEO both inside and outside the biotech
industry. Beginning in 1997, Hawthorne developed and coordinated the
Missyplicity Project, the world's first large-scale dog and cat cloning research
project, which produced the world's first cat clone in 2001. In 2000, Hawthorne
founded Genetic Savings & Clone, which produced the world's first commercial
cat clones in 2004. Hawthorne and GSC consistently made headlines globally
with their innovative work in the companion animal space.

In late 2006,Hawthorne founded BioArts International where he now serves as CEO. BioArtshas been successful in commercially cloning the world’s first family dog.
Hawthorne graduated from Princeton University in 1983 with a degree in
English Literature, after which he worked as a software designer and media
producer for various Fortune 500 companies. From the beginning of the
Missyplicity Project, Hawthorne studied the science of cloning by direct
interaction with pioneers in the field. Some of these pioneers now serve as
advisors, partners or employees of BioArts.

Hawthorne has a 7 year-old son, Skye. They enjoy playing music, doing math,
watching Star Trek and hiking the hills of Marin. Hawthorne also enjoys the
newest addition to his family: his cloned puppy Mira.

BioArts International